Back to search results

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

Abroad (travel likely)Recruiting

Conditions

Chronic Limb-Threatening Ischemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • NYU Langone Health, New York, New York, United States

    Contact: Study coordinator (Natalie Massenburg) · natalie.massenburg@nyulangone.org · (646) 634-6178
    Contact: Principal Investigator (Anvar Babaev, M.D.)

  • CUMC/NYP, New York, New York, United States

    Contact: Study coordinator (Treena Williams, MS) · taw2112@cumc.columbia.edu · 1(212)342-3485
    Contact: Principal Investigator (Sahil A. Parikh, MD)

  • Staten Island University Hospital - Northwell Health, Staten Island, New York, United States

    Contact: Study coordinator (Brandon Dilluvio) · bdilluvio@northwell.edu · (718)226-1997
    Contact: Principal Investigator (Mitchell Weinberg, M.D.)
Study leads

  • Eric Secemsky, MD

    Principal Investigator

    Beth Israel Deaconess Medical Center

  • Marianne Brodmann, MD

    Principal Investigator

    Medical University of Graz

  • Ramon L Varcoe, MD

    Principal Investigator

    Prince of Wales Private Hospital

View source on ClinicalTrials.gov(opens in a new tab)